Overview
Mei Tang is a Hematologist in Towson, Maryland. Dr. Tang is highly rated in 43 conditions, according to our data. Her top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Myelodysplastic Syndrome (MDS), and Large-Cell Immunoblastic Lymphoma.
Her clinical research consists of co-authoring 51 peer reviewed articles and participating in 25 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6569 N Charles St Ste 201, Towson, MD 21204
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
25 Clinical Trials
Office
Taofeek Owonikoko is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.
Johns Hopkins Bayview Medical Center
Patrick Forde is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Forde is highly rated in 12 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Mesothelioma, and Small Cell Lung Cancer (SCLC).
Johns Hopkins Hospital
Michael Streiff is a Hematologist in Baltimore, Maryland. Dr. Streiff is highly rated in 34 conditions, according to our data. His top areas of expertise are Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Mei Tang
How do I make an appointment with Dr. Mei Tang?
You can book an appointment with Dr. Mei Tang by calling their office at 443-849-3051. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mei Tang a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mei Tang is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mei Tang specialize in?
While Dr. Mei Tang is a Hematology, they have specific expertise in Lung Cancer, Small Cell Lung Cancer (SCLC), and Myelodysplastic Syndrome (MDS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Mei Tang participate in research or clinical trials?
Yes. Dr. Mei Tang has published 51 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Mei Tang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mei Tang accept my insurance?
Dr. Mei Tang accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 443-849-3051 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Large-Cell Immunoblastic LymphomaDr. Tang isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Laryngeal CancerDr. Tang isDistinguished. Learn about Laryngeal Cancer.
- Lung CancerDr. Tang isDistinguished. Learn about Lung Cancer.
- MelanomaDr. Tang isDistinguished. Learn about Melanoma.
- Myelodysplastic Syndrome (MDS)Dr. Tang isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Pleuropulmonary BlastomaDr. Tang isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Adult Immune ThrombocytopeniaDr. Tang isAdvanced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung Cancer
- Antiphospholipid SyndromeDr. Tang isAdvanced. Learn about Antiphospholipid Syndrome.
- Breast CancerDr. Tang isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Eosinophilic PneumoniaDr. Tang isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Tang isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Tang isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation